Updated Jul 16, 2026
Cohen Fred E has filed 3 SEC Form 4 filings across 3 companies in the last 90 days — buying. Lifetime open-market purchases: $1.40M.
Fred E. Cohen is identified in SEC filings as an insider associated with CareDx, Inc. (CDNA) and Intellia Therapeutics, Inc. (NTLA) as of the filing period ending January 7, 2026. The filings show no equity purchases or sales by him and report a total of three filings; his specific role or title is not disclosed in the provided context.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-16 | CDNA | CareDx, Inc. | A — Grant or award | 9.8K | $0.00 | |
| 2026-06-10 | NTLA | Intellia Therapeutics, Inc. | A — Grant or award | 9.2K | $0.00 | |
| 2026-05-29 | KYTX | Kyverna Therapeutics, Inc. | A — Grant or award | 5.1K | $0.00 | |
| 2026-01-07 | NTLA | Intellia Therapeutics, Inc. | P — Open-market purchase | 150.0K | $9.35 | $1.40M |
| 2025-06-13 | CDNA | CareDx, Inc. | A — Grant or award | 12.1K | $0.00 |
Fred E. Cohen is identified in SEC filings as an insider associated with CareDx, Inc. (CDNA) and Intellia Therapeutics, Inc. (NTLA) as of the filing period ending January 7, 2026. The filings show no equity purchases or sales by him and report a total of three filings; his specific role or title is not disclosed in the provided context.…
3 primary Form 4 filings in the last 90 days, covering 3 companies.
Recorded transactions: 1 open-market purchases ($1.40M) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Cohen Fred E profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.